Overview

Bioequivalence Study of Venlafaxine Hydrochloride Sustained-Release Capsules in Chinese Healthy Volunteers

Status:
Recruiting
Trial end date:
2020-07-02
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the human bioequivalence of two Venlafaxine Hydrochloride Sustained-Release Capsules (75 mg) .
Phase:
N/A
Details
Lead Sponsor:
Beijing Tongren Hospital
Treatments:
Venlafaxine Hydrochloride